150 mg VISMO Pill - pink gray capsule/oblong, 19mm
Generic Name: vismodegib
Pill with imprint 150 mg VISMO is Pink / Gray, Capsule/Oblong and has been identified as Erivedge 150 mg. It is supplied by Genentech, Inc.
Erivedge is used in the treatment of Basal Cell Carcinoma and belongs to the drug class hedgehog pathway inhibitors. There is positive evidence of human fetal risk during pregnancy. Erivedge 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 150 mg VISMO
Erivedge
- Generic Name
- vismodegib
- Imprint
- 150 mg VISMO
- Strength
- 150 mg
- Color
- Pink / Gray
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Hedgehog pathway inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0140
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
sodium lauryl sulfate,
povidone k30,
sodium starch glycolate type A potato,
magnesium silicate,
magnesium stearate,
titanium dioxide,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about Erivedge (vismodegib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hedgehog pathway inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
